Childrens Hospital Colorado endocrinologist Melanie Cree, MD, PhD, has dedicated her research to better understanding this disease and its relationship to the essential hormone insulin
As the first GLP-1 receptor agonist to demonstrate landmark weight loss results, it proved that the bodys own satiety signals could be harnessed to produce sustained, meaningful fat loss, and became the gold standard that all subsequent therapies are still measured against
GC-MS parameters were as follows: for sterols: carrier gas, helium
Side effects Common side effects Nausea Diarrhea Vomiting Constipation Abdominal pain Headache Fatigue Injection site reactions Other potential side effects: Indigestion Dizziness Back pain Increased lipase or amylase Altered taste Nasopharyngitis (common cold) Passing gas Bloating Belching Gastroenteritis Decreased appetite Gastroesophageal reflux disease Upset stomach These symptoms often subside as your body adjusts to the medications
Clinical Context for GLP-1 Medications in 2026 This is not about Found Health specifically - this is about understanding the medications themselves so you can have an informed conversation with your provider about what might be appropriate for you